Skip to main content

Feeley Kevin's Form 4 filing

GeneDx Holdings Corp. (WGS) · filed Oct 1, 2025

Accession no.
0001944119-25-000012
Filed
Oct 1, 2025
Trade date
Sep 30, 2025
Filing delay
1 day
Rule 10b5-1 plan
Checked

This filing lists 8 non-derivative transactions and 1 derivative transaction. Open-market sales total $716.3K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Feeley KevinCIK 0001944119Officer (CHIEF FINANCIAL OFFICER)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 30, 2025Class A Common StockMOption exerciseAcquired+1,246$32.67+$40,706.8210,001Direct
Sep 30, 2025Class A Common StockSSaleDisposed−344$105.24F2−$36,202.569,657Direct
Sep 30, 2025Class A Common StockSSaleDisposed−387$106.86F3−$41,354.829,270Direct
Sep 30, 2025Class A Common StockSSaleDisposed−2,715$107.68F4−$292,351.26,555Direct
Sep 30, 2025Class A Common StockSSaleDisposed−2,152$108.67F5−$233,857.844,403Direct
Sep 30, 2025Class A Common StockSSaleDisposed−421$110.05F6−$46,331.053,982Direct
Sep 30, 2025Class A Common StockSSaleDisposed−520$111.93F7−$58,203.63,462Direct
Sep 30, 2025Class A Common StockSSaleDisposed−70$113.68−$7,957.63,392Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 30, 2025Class A Common StockMOption exerciseDisposed−1,246$0.00$04,982Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.98 to $105.91, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 3 through 7.

Referenced by the price of 1 transaction in Table I.

F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.1354 to $107.01, inclusive.

Referenced by the price of 1 transaction in Table I.

F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.22 to $108.20, inclusive.

Referenced by the price of 1 transaction in Table I.

F5

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.23 to $109.1754, inclusive.

Referenced by the price of 1 transaction in Table I.

F6

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.3225 to $110.25, inclusive.

Referenced by the price of 1 transaction in Table I.

F7

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.50 to $112.04, inclusive.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)